corticosterone has been researched along with Parkinsonian Disorders in 9 studies
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, M | 1 |
| Bohlen, JK | 1 |
| Moore, C | 1 |
| Nipper, MA | 1 |
| Finn, DA | 1 |
| Jones, CE | 1 |
| Lim, MM | 1 |
| Meshul, CK | 1 |
| Grembecka, B | 1 |
| Glac, W | 1 |
| Listowska, M | 1 |
| Jerzemowska, G | 1 |
| Plucińska, K | 1 |
| Majkutewicz, I | 1 |
| Badtke, P | 1 |
| Wrona, D | 1 |
| Hao, Y | 1 |
| Shabanpoor, A | 1 |
| Metz, GA | 2 |
| Dallé, E | 1 |
| Daniels, WMU | 1 |
| Mabandla, MV | 1 |
| Kim, KS | 2 |
| Kang, YM | 1 |
| Kang, Y | 1 |
| Park, TS | 1 |
| Park, HY | 1 |
| Kim, YJ | 1 |
| Han, BS | 1 |
| Kim, CH | 1 |
| Lee, CH | 1 |
| Ardayfio, PA | 1 |
| Han, PL | 1 |
| Jung, BH | 1 |
| Barnum, CJ | 1 |
| Eskow, KL | 1 |
| Dupre, K | 1 |
| Blandino, P | 1 |
| Deak, T | 1 |
| Bishop, C | 1 |
| GILLHESPY, RO | 1 |
| RATCLIFFE, AH | 1 |
| Carlson, KM | 1 |
| Wagner, GC | 1 |
| Smith, LK | 1 |
| Jadavji, NM | 1 |
| Colwell, KL | 1 |
| Katrina Perehudoff, S | 1 |
9 other studies available for corticosterone and Parkinsonian Disorders
| Article | Year |
|---|---|
Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Corticosterone; Disease Mode | 2019 |
Subthalamic Deep Brain Stimulation Affects Plasma Corticosterone Concentration and Peripheral Immunity Changes in Rat Model of Parkinson's Disease.
Topics: Animals; Corticosterone; Deep Brain Stimulation; Male; Neuroimmunomodulation; Parkinsonian Disorders | 2021 |
Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
Topics: Adrenalectomy; Animals; Corticosterone; Disease Models, Animal; Dopamine; Male; Membrane Proteins; M | 2017 |
Fluvoxamine maleate effects on dopamine signaling in the prefrontal cortex of stressed Parkinsonian rats: Implications for learning and memory.
Topics: Animals; Corticosterone; Dopamine; Fluvoxamine; Learning; Learning Disabilities; Lipid Peroxidation; | 2017 |
Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain; Comorbidity; Corticosterone; Depressive Disorder; | 2014 |
Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.
Topics: Animals; Anti-Inflammatory Agents; Corpus Striatum; Corticosterone; Disease Models, Animal; Dose-Res | 2008 |
Treatment of Parkinsonism with a new compound (B.S.5930).
Topics: Corticosterone; Diphenhydramine; Parkinson Disease; Parkinsonian Disorders | 1955 |
Voluntary exercise and tail shock have differential effects on amphetamine-induced dopaminergic toxicity in adult BALB/c mice.
Topics: Amphetamine; Animals; Cell Survival; Corpus Striatum; Corticosterone; Dopamine; Drinking; Eating; El | 2006 |
Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease.
Topics: Animals; Brain; Corticosterone; Female; Motor Activity; Movement Disorders; Nerve Degeneration; Park | 2008 |